Sleep benefit

Author(s):  
Lana Chahine
Keyword(s):  
2022 ◽  
Author(s):  
Sabrina Berres ◽  
Edgar Erdfelder

People recall more information after sleep than after an equally long period of wakefulness. This sleep benefit in episodic memory has been documented in almost a century of research. However, an integrative review of hypothesized underlying processes, a comprehensive quantification of the benefit, and a systematic investigation of potential moderators has been missing so far. Here, we address these issues by analyzing 823 effect sizes from 271 independent samples that were reported in 177 articles published between 1967 and 2019. Using multilevel meta-regressions with robust variance estimates, we found a moderate overall sleep benefit in episodic memory (g = 0.44). Moderator analyses revealed four important findings: First, the sleep benefit is larger when stimuli are studied multiple times instead of just once. Second, for word materials, the effect size depends on the retrieval procedure: It is largest in free recall, followed by cued recall and recognition tasks. Third, the sleep benefit is stronger in pre-post difference measures of retention than in delayed memory tests. Fourth, sleep benefits are larger for natural sleep and nighttime naps than foralternative sleep-study designs (e.g., SWS-deprived sleep, daytime naps). Although there was no obvious evidence for selective reporting, it is a potential threat to the validity of the results. When accounting for selective reporting bias, the overall effect of sleep on episodic memory is reduced but still significant (g = 0.28). We argue that our results support an integrative, multi-causal theoretical account of sleep-induced episodic memory benefits and provide guidance to increase their replicability.


2014 ◽  
Vol 20 (1) ◽  
pp. 116-118 ◽  
Author(s):  
Eskender Sherif ◽  
Philipp O. Valko ◽  
Sebastiaan Overeem ◽  
Christian R. Baumann

SLEEP ◽  
2021 ◽  
Vol 44 (Supplement_2) ◽  
pp. A331-A331
Author(s):  
Moustapha Doulaye Seydou ◽  
Christian Karime ◽  
Brenda Wyrick ◽  
Amir Khan

Abstract Introduction Narcolepsy represents a relatively rare chronic neurological sleep disorder. While peak incidence occurs in adolescence and early-adulthood, reports indicate a substantial number of children under 10 remain undiagnosed or are misdiagnosed. The present case describes a female with undiagnosed narcolepsy type II self-medicating with caffeinated beverages from the age of 7. Report of case(s) A 40-year-old female presented at our clinic with excessive daytime fatigue and hypersomnolence despite adequate sleep (Epworth sleepiness scale= 16/24). The patient denied snoring, sleep paralysis, catalepsy, and hypnagogic/hypnopompic hallucinations. Symptoms began at the age of 7 and steadily worsened, with teachers reporting significant concentration difficulties and multiple episodes of unintentional sleep onset in the classroom. The patient reported heavily relying on caffeinated beverages from the age of 7 to remain awake and focused on classroom activities. Starting at the age of 7, the patient consumed on average a caffeine-equivalent of 1 espresso shot/day (64mg caffeine/day). This increased to 4–6 espresso shots/day (256-384mg caffeine/day) by the age of 12 and 5–9 espresso shots/day (320-576mg caffeine/day) by the age of 18. At the age of 25, the patient developed severe anxiety with panic attacks and episodes of suicidal ideation. With multiple episodes of sleep onset while operating a motor vehicle, a near-accident prompted medical evaluation. Diagnosed with general anxiety disorder and idiopathic hypersomnolence, escitalopram and armodafinil were started with limited effect. The patient continued self-medicating with caffeinated beverages until age 38 when she was diagnosed with narcolepsy type II. Sodium oxybate was subsequently added to her treatment plan with initial sleep benefit and caffeine reduction. A repeat mean sleep latency test confirmed narcolepsy type II (mean sleep latency= 3 minutes, mean rapid eye movement [REM] sleep latency= 3 minutes). Polysomnography was later performed due to non-resolving symptoms, revealing mild obstructive sleep apnea (REM apnea-hypopnea index= 13.5/hour). Continuous positive airway pressure was added to the treatment regime with significant sleep benefit. Conclusion We describe a case of undiagnosed childhood narcolepsy type II necessitating significant caffeine consumptions in order to maintain classroom performance. With known anxiety-provoking effects of caffeine, the case highlights the importance of addressing childhood narcolepsy. Support (if any):


2012 ◽  
Vol 2 (2) ◽  
pp. 167-170 ◽  
Author(s):  
Merel M. van Gilst ◽  
Maartje Louter ◽  
Christian R. Baumann ◽  
Bastiaan R. Bloem ◽  
Sebastiaan Overeem

2012 ◽  
Vol 18 (5) ◽  
pp. 662-663 ◽  
Author(s):  
Madhu Nagappa ◽  
Ravindranadh Chowdary Mundlamuri ◽  
P. Satishchandra ◽  
Pramod Kumar Pal

2019 ◽  
Vol 137 ◽  
pp. 103659
Author(s):  
Dimitri Vast ◽  
Yannick Gounden ◽  
Véronique Quaglino

Sign in / Sign up

Export Citation Format

Share Document